Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

2.6K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.6K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

138
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

160
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
160

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Generation of a Ym1 deficient mouse utilising CRISPR-Cas9 in CB6 embryos.

Transgenic research·2025
Same author

Leveraging metabolic modeling to identify functional metabolic alterations associated with COVID-19 disease severity.

Metabolomics : Official journal of the Metabolomic Society·2022
Same author

Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.

mSphere·2021
Same author

Solitary and periodic waves in collisionless plasmas: The Adlam-Allen model revisited.

Physical review. E·2020
Same author

Enhanced monocyte recruitment and delayed alternative macrophage polarization accompanies impaired repair following myocardial infarction in C57BL/6 compared to BALB/c mice.

Clinical and experimental immunology·2019
Same author

Management of Barrett's esophagus with low-grade dysplasia.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2018
Same journal

Anti-biofilm activity of coated zinc oxide nanoparticles in a water-in-oil formulation against Cutibacterium acnes.

Anaerobe·2026
Same journal

The Impact of Fecal Microbiota Transplantation on Host Immunity and Epithelial Restoration Following Clostridioides difficile Infection.

Anaerobe·2026
Same journal

Evaluation of molecular thresholds based quantification of Gardnerella vaginalis and Fannyhessea vaginae for improved diagnosis of Bacterial Vaginosis.

Anaerobe·2026
Same journal

<sup>1</sup>H NMR metabolomic profiling of Methanobacterium and Methanosarcina reveals unusual intracellular trimethylamine and acetamide production.

Anaerobe·2026
Same journal

Reproducibility Assessment of the Crystal Violet Biofilm Assay in Clostridioides difficile.

Anaerobe·2026
Same journal

Clostridioides difficile in chicken fresh meat at retail in France.

Anaerobe·2026
查看所有相关文章

相关实验视频

Updated: Jun 27, 2025

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.5K

IL-13可以保护人免受Clostridioides困难结肠炎的侵害.

A N Donlan1, J L Leslie2, M E Simpson3

  • 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, 98109, USA; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, VA, 22908, USA.

Anaerobe
|May 3, 2024
PubMed
概括
此摘要是机器生成的。

介乐-13 (IL-13) 管理保护了小鼠的Clostridioides difficile感染 (CDI),同时阻止IL-13恶化疾病. 这突出了IL-13的特点.

关键词:
这是C. difficile.它们有IL-13和IL-13.豁免权是一种豁免权.第二种类型的免疫.

更多相关视频

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.5K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.9K

相关实验视频

Last Updated: Jun 27, 2025

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.5K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.5K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.9K

科学领域:

  • 免疫学 免疫学 免疫学
  • 微生物学 微生物学
  • 胃肠病学 胃肠病学

背景情况:

  • 艰难菌感染 (CDI) 是一个主要的医院获得的感染.
  • 抗生素的使用破坏了肠道微生物群,减少了像IL-33和IL-25这样的保护性细胞因子.
  • 通过ILC2s传递IL-33信号产生IL-13,但IL-13在CDI中的作用尚不清楚.

研究的目的:

  • 在CDI的小鼠模型中研究IL-13的作用.
  • 为了确定IL-13是否影响CDI期间的疾病严重程度和免疫细胞反应.

主要方法:

  • 使用了经过验证的CDI小鼠模型.
  • 服用复合IL-13或阻断IL-13的抗体.
  • 使用减肥和临床分数分析疾病严重程度.
  • 使用光激活细胞分类 (FACS) 鉴定了髓状细胞群的特征.

主要成果:

  • 给予IL-13给予了对CDI的保护.
  • 阻断IL-13加剧了CDI的严重程度.
  • IL-13中和改变了单细胞/巨细胞的数量,增加了髓状细胞的积累.
  • 中和受体IL-13诱受体 (IL-13Rα2) 保护免受CDI.

结论:

  • IL-13在CDI中起着保护作用,减轻了疾病的严重程度.
  • 单细胞/巨细胞区的失调与对CDI的反应不佳有关.
  • 这些发现增强了对CDI2型免疫的理解,并表明了治疗潜力.